Claris Bio

About Claris Bio

Claris Bio is dedicated to improving lives by addressing unmet needs in ophthalmology through robust science and data-driven decision-making, with a focus on leading advancements in corneal therapy.

Products & Services

CSB-001:A topical ocular biologic solution of dHGF (hepatocyte growth factor), aimed at restoring structural and functional corneal integrity for eyes with Limbal Stem Cell Deficiency (LCSD).

Specialties

Corneal therapy Ophthalmology drug development Hepatocyte growth factor (HGF) research Limbal Stem Cell Deficiency (LCSD) treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 57000000 MR: - FA: 57 million FAN: 57000000	D: 2024-01-04 FD: 2024-01-04	4 investors

Series A Latest

2024-01-04

$57.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Reza Dana

CO-FOUNDER AND BOARD MEMBER

S

Sunil Chauhan

CO-FOUNDER AND SCIENTIFIC ADVISOR

C

Clarke Atwell

Founding CEO and Board Member

S

Susan Orr

Chief Medical Officer

H

Henry Rath

Chief Business Officer

T

Tomi Luan

Vice President, Clinical Development

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Claris Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised